Assertio to Present at the Citizens JMP Life Sciences Conference in New York City
10 Mayo 2024 - 2:12PM
Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq:
ASRT), a pharmaceutical company with comprehensive commercial
capabilities offering differentiated products to patients, today
announced that Ajay Patel, Chief Financial Officer, will present at
the Citizens JMP Life Sciences Conference to be held May 13, 2024
in New York City.
The Company will host a group presentation at 12:00 pm Eastern
Time, and be available for individual meetings throughout the day.
Attending investors interested in meeting with the Company can
request a meeting via their JMP representative, or contact Assertio
investor relations via mkreps@darrowir.com.
Presentation information will be available on the day of the
event and can accessed at https://investor.assertiotx.com. To
listen to the presentation webcast, please connect to the website
link at least 15 minutes prior to the live webcast to ensure
adequate time for any software download that may be needed.
About Assertio
Assertio is a commercial pharmaceutical company offering
differentiated products to patients. We have built our commercial
portfolio through acquisition or licensing of approved products.
Our comprehensive commercial capabilities include marketing through
both a sales force and a non-personal promotion model, market
access through payor contracting, and trade and distribution. To
learn more about Assertio, visit www.assertiotx.com.
Forward Looking Statements
Statements in this communication that are not historical facts
are forward-looking statements that reflect Assertio’s current
expectations, assumptions and estimates of future performance and
economic conditions. These forward-looking statements are made in
reliance on the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These forward-looking
statements relate to, among other things, future events or the
future performance or operations of Assertio, including risks
related to our ability to realize the benefits from our operating
model, successfully integrate new assets, explore new business
development initiatives, and successfully recruit a successor CEO
on a timely basis. All statements other than historical facts may
be forward-looking statements and can be identified by words such
as “anticipate,” “believe,” “could,” “design,” “estimate,”
“expect,” “forecast,” “goal,” “guidance,” “imply,” “intend,” “may,”
“objective,” “opportunity,” “outlook,” “plan,” “position,”
“potential,” “predict,” “project,” “prospective,” “pursue,” “seek,”
“should,” “strategy,” “target,” “would,” “will,” “aim” or other
similar expressions that convey the uncertainty of future events or
outcomes and are used to identify forward-looking statements. Such
forward-looking statements are not guarantees of future performance
and are subject to risks, uncertainties and other factors, some of
which are beyond the control of Assertio, including the risks
described in Assertio’s Annual Report on Form 10-K and Quarterly
Reports on Form 10-Q filed with the U.S. Securities and Exchange
Commission (“SEC”) and in other filings Assertio makes with the SEC
from time to time. Investors and potential investors are urged not
to place undue reliance on forward-looking statements in this
communication, which speak only as of this date. While Assertio may
elect to update these forward-looking statements at some point in
the future, it specifically disclaims any obligation to update or
revise any forward-looking-statements contained in this press
release whether as a result of new information or future events,
except as may be required by applicable law.
Investor Contact
Matt Kreps, Managing DirectorDarrow AssociatesM:
214-597-8200mkreps@darrowir.com
Assertio (NASDAQ:ASRT)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Assertio (NASDAQ:ASRT)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024